• Spectrum Global Solutions provides end-to-end market offerings for communications networks, including building infrastructure for wireless and wired-in products and maintaining existing networks
• In a world that is increasingly interconnected through wireless technology, network services occupy a turnkey position and keep the machinery humming
• The pending rollout of 5G-speed networks promises to be a boon for fans of smart home products and streaming video services who rely on fast network capability, and Spectrum is positioned to help build the 5G future
• The smart home product market was estimated at about $10 billion last year and is expected to grow by 50 percent each year through 2021

As the global race to adopt and adapt to higher-speed 5G networks heats up, wireless service providers will need more spectrum, and Spectrum Global Solutions Inc. (OTCQB: SGSI) is positioned to respond to those needs.

Spectrum Global is a holding company operating as an end-to-end telecommunications network service provider whose subsidiaries play key roles in the design, construction and maintenance of both wireless and wireline projects for carriers, aggregators, enterprise services, project management offices (PMOs) and original equipment manufacturers (OEMs) of all sizes, including well-known names such as Ericsson, Nokia, Sprint, AT&T and Verizon.

The company’s subsidiaries, AW Solutions Inc. and ADEX Corporation and their Puerto Rico LLC divisions; Florida Tropical Communications Inc.; and Illinois T N S Inc., provide communications infrastructure deployment, telecommunications project lifetime services and wiring needs. The services are taking on turnkey importance as all facets of the tech industry anticipate the launch of 5G networks that could raise the bar for transmission speeds by 10 to 100 times, beginning in the coming year.

Those transmission speeds are increasingly important to the consumer market as OTT video services gain a preferential hold on much of the television-watching market. Netflix garnered attention last month when it announced that viewership for its third season of the streaming series ‘Stranger Things’ was up to 40.7 million household accounts and that 18.2 million had already finished watching the entire season (http://ibn.fm/5uakD). While insiders acknowledge that it’s still impossible to directly compare Netflix’s viewership with standard at-home TV watchers, the rising popularity of streaming services with adult consumers appears to be undisputed.

In addition, homes are increasingly connected to their owners’ mobile products through smart applications. Global market research company IHS reported that 98 million smart home devices worth about $10 billion dollars were sold last year in the United States, and IHS predicts that the market will continue to grow by 50 percent yearly through 2021 (http://ibn.fm/HR7bJ). Those smart applications are dependent on networks that are sufficiently fast to stream data including video, in real time.

“The market opportunity is immense,” SGSI President Keith Hayter told The RedChip Money Report at the beginning of the year (http://ibn.fm/fqLlj). “We’re in a high-growth market… Over $1.5 trillion is going to be spent on telecommunications. For deployment services, which is where we primarily fit in and get our revenue streams from, from $150 (billion) to $200 billion will be spent over the next couple of years.”

For more information, visit the company’s website at www.SpectrumGlobalSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

• Pivotal’s gas flow monitoring and control solutions are unrivaled in speed, precision and sensing capabilities
• The company boasts strong customer retention rates, maintaining close relationships with leading blue-chip integrated device manufacturers and original equipment manufacturers
• Pivotal’s global footprint includes production facilities in the U.S., China and Korea, with sales offices located throughout the Asia-Pacific Region, Japan and Europe

Pivotal Systems Corporation (ASX: PVS), a leading global provider of best-in-class gas flow control solutions that are integral to the production of semiconductors, continues to build its customer base and increase profit margins with new and repeated sales orders from clients located throughout the world. Pivotal Systems Corporation is listed on the Australian Securities Exchange (ASX).

Pivitol’s portfolio of gas flow controllers (“GFCs”) and flow ratio controllers (“FRCs”) assists semiconductor manufacturers hoping to stabilize and control the delivery of gases used to deposit or remove materials during the semiconductor manufacturing process. Pivotal’s GFC product lines offer high accuracy, real-time monitoring and control of the most critical parameters that are difficult to handle in wafer processing today, including gas flow and chamber condition.

Pivotal recently conducted live demonstrations of several of its products, including the High Flow GFC, the Flow Ratio Controller and the Ultra-High Speed Control System running at microsecond speeds, at SEMICON West in San Francisco. John Hoffman, chairman and CEO of Pivotal Systems, also presented at the 11th Annual CEO Summit, held concurrently with SEMICON West, delivering a detailed review of 2018 and the company’s product timeline (http://ibn.fm/DyxNJ).

Pivotal successfully launched an initial public offering (IPO) on the ASX in July 2019, raising $39.6 million (A$53.5 million) to expand operations in Korea, Japan, Taiwan, China and the U.S., as the company noted in a news release (http://ibn.fm/bTsvF).

“We have seen a fantastic level of investor support, which reflects our plans to expand our capabilities and provide increasingly valuable technology to our global customers,” Hoffman stated in a news release. “By utilizing cutting-edge proprietary hardware and the most advanced software in our industry, we provide real value when it comes to overcoming many of the flow control challenges advanced semiconductor manufacturers face.”

The company’s strong revenue growth in 2018 – up 32 percent as a result of increasing market share – translates into a strong financial position within a multibillion-dollar industry. The company’s machine learning platform enables a new generation of intelligent industrial controls that can drive productivity in many applications. Pivotal has production capabilities in the U.S. and contracted facilities in China and Korea, with sales offices located throughout the Asia-Pacific region, Japan and Europe.

For more information, visit the company’s website at www.PivotalSys.com

• Sports performance medicine and nutrition is a strong focus for Neutra. As the company’s new Sports Performance Medical Advisor, Dr. Cherry will continue his recent work designing tailored medical programs and services focused on human performance.
• Neutra will aggressively target the promising sports nutrition market, a segment with sales that are currently expected to reach $11 billion by 2023.
• Neutra is developing third-party certified hemp-derived CBD health and nutritional product lines for consumers.
• Hemp-based CBD consumer projects generated sales of up to $390 million in 2018 with analysts predicting sales of hemp-based products could reach $22 billion by 2022.
• Leadership has a proven track record of adding value for public company shareholders.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

• Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
• J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

• Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
• ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

For more information, visit the company’s website at www.NeutraInc.com

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR

• BacTech Environmental is an Ontario, Canada-based company that uses microbial bacteria for “bioleaching” the arsenic from historic and often-abandoned mine projects, leaving the sites environmentally restored and making their precious metals easier to process
• The company has attained equity interests in mine remediation projects in Bolivia and Ecuador, and it is working with Ontario’s Cambrian College to identify the “best bugs” to tackle the arsenic in those countries
• BacTech recently strengthened its financing with a two-tranche funding effort that’s expected to bring in $125,000

Environmental remediation at mine tailing sites has gained a natural, even holistic, advocate in the form of BacTech Environmental Corp. (CSE: BAC) (OTC: BCCEF), a Toronto-based “bioleaching” corporation that aims to put microbes to work in stabilizing dangerous arsenic mine waste and recovering more precious metals in the process.

“Our Bugs Eat Rocks,” one company video presentation declared in 2013 (http://ibn.fm/PjkJd). CEO and President Ross Orr explained in the video how BacTech’s proprietary technology was being primed for use in cleaning up tailings at the former Telamayu project in Bolivia – a mill that received ore for processing for nearly a century from various mines in the area until it was abandoned over 50 years ago.

The plan is to use naturally occurring bacteria to clean up sulfide tailings at such projects, he said.

“The tailings there (in Bolivia) have been oxidizing for some time and releasing acid mine drainage into the local river, which of course goes right into the town of Atocha next door,” Orr added.

Orr issued a call for funding the cleanup project through the medium of the video, a request that has been repeated a number of times since. Last month, BacTech announced its most recent success in obtaining capital to advance its bioleaching project, referring to a two-tranche private placement financing effort that’s expected to bring in $125,000 (http://ibn.fm/ZOj1S).

A second BacTech project involves the potential use of bioleach processing to treat historic arsenopyrite concentrates and tailings produced in Southern Ecuador by small mom-and-pop operations. Environmental microbiologist Nadia Mykytczuk has been working with BacTech to identify the best bacteria for the region’s needs and the ideal conditions for nurturing their growth inside fermentation tanks where the arsenic is stabilized even as precious metals are recovered. A research project has also grown out of the Ecuadorean reclamation effort, including a test facility with bioreactors at Cambrian College in Sudbury, near Toronto, according to publication Northern Ontario Business (http://ibn.fm/7LDgx).

“We’ve completed a year’s worth of test work to find the best bugs, under the best conditions, to extract the gold out of this high arsenic material,” Mykytczuk told Northern Ontario Business. “If you take a handful of tailings from Copper Cliff or Ecuador you have thousands to millions of individual organisms, and that diversity matters because those bugs are best adapted to those conditions. Nature knows best. It will have picked bugs that can grow in a particular situation. My goal is to demonstrate that we can use this technology to reprocess the many thousands of abandoned mines here that still hold a lot of value.”

BacTech Environmental’s strategy includes seeking an equity position in each remediation project it undertakes and augmenting related revenues with additional cash flow proceeding from metal recovery. Where possible, the company will also pursue governmental and non-governmental organization (NGO) funding for the projects.

The company notes that its strategy is based on the global demand for cleaning up mining areas as world populations become ever-more environmentally conscious, as well as the potential revenue stream resulting from the interest in remediation, as opposed to simple revenues from licensing the bioleaching technology to other firms for their uses.

For more information, visit the company’s website at www.BacTechGreen.com

• Sonic Automotive ranks among the top five retail automotive groups in the United States each year, as reported by industry publication Automotive News
• The company has a new vehicle-centered retail division and its EchoPark Automotive used car division, both focused on innovations to the buying experience
• During the second quarter, EchoPark’s sales grew by 68.7 percent as new vehicle sales volume slowed
• Despite a downturn in new vehicle sales during the quarter, Sonic’s total sales established a number of consolidated all-time quarterly records

Innovative automotive retailer Sonic Automotive Inc. (NYSE: SAH) is a Fortune 500 company that consistently ranks among the top five largest retail automotive groups in the United States, growing from a small business with 20 stores in 1997 to a group of more than 100 stores selling 24 brands currently.

Sonic was one of seven U.S. retailers to report over 100,000 new vehicle sales last year, rising to just shy of 300,000 units sold when used and wholesale transactions were factored in. Total revenues for the group were $9.95 billion (http://ibn.fm/lW9NF).

Under the company’s One Sonic One Experience campaign, introduced in 2014, non-commissioned sales representatives work with shoppers over the course of about an hour to make buying a vehicle an enjoyable experience by “eliminating all the pain points” that can accompany identifying the right vehicle and subsequent negotiations. The company’s priority on transparency extends from the service area to trade-in valuations, and it purchases consumers’ vehicles without trade-in requirements.

Sonic’s EchoPark Automotive segment is the corporate arm that deals in used cars and light trucks, helping to arrange additional finance and insurance product sales in eight specialty retail locations across North Carolina, Texas and Colorado.

EchoPark’s retail sales topped 12,500 vehicles during the second quarter of 2019, marking an increase of 68.7 percent from the previous year’s second quarter.

“Even as the new vehicle market started showing signs of weakness (during the second quarter), we still had record results in our pre-owned and F&I business lines and grew our fixed operations by 6.4 percent,” CEO David Smith stated in a company news release issued July 25 (http://ibn.fm/6Ma3u). “This, once again, shows how the dynamic dealer operating model benefits from multiple revenue streams. We are very excited to see the maturity of our current EchoPark locations as illustrated by our most mature market, Denver, Colorado… It is very exciting to see the results when you focus on the customer and use technology and process to reduce your expenses and simplify the operational model. We believe we will be able to open an additional EchoPark store before the end of 2019 and another shortly thereafter in the first half of 2020. Our current plans include two additional EchoPark store openings in the second half of 2020.”

EchoPark’s revenues of $291.7 million during the second quarter put the company on track to exceed $1.1 billion by year’s end, and Sonic’s total sales established a number of consolidated all-time quarterly records, according to the report. The company’s board of directors approved a quarterly dividend of $0.10 per share payable in cash for stockholders of record on September 13, 2019.

For more information, visit the company’s website at www.SonicAutomotive.com

• Trxade Group helps sustain independent pharmacies through its web-based purchasing platform, network of locally run pharmacies, data analytics and delivery services
• Independent pharmacists often find themselves at the forefront of the battle over health care costs, working to stay afloat as drug costs rise and insurer reimbursements fall
• The value of independent pharmacies lies in the sense of community that they have helped instill for decades among their patients, and, as the small businesses close their doors, they leave behind ‘pharmacy deserts’ bereft of close-to-home services
• Trxade Group reported record revenues of over $1.9 million in its second quarter filing through its services in support of independent pharmacies; its network of such pharmacies continues to grow

Independent, locally operated pharmacies have long been one of the most familiar ways of defining a community’s lifestyle. While their heyday may be decades in the past – an era when teens and adults alike sat on bar stools listening to the jukebox while sipping a soda or enjoying some ice cream – many small business entrepreneurs continue to stubbornly define their pride in their local neighborhoods by the traffic that comes through the family-owned pharmacies’ front doors.

Florida-based Trxade Group Inc. (OTCQB: TRXD), a pharmaceutical services network that has established its own community of trust, technology and transparency through a trademarked supplier-to-pharmacy (S2P) trading platform, is bringing the buyers and sellers of medicinal products and services together to support the locally minded independent businesses nationwide, helping them to identify the best available sourcing and pricing for prescription drugs.

A key challenge to the existence of independent pharmacies in the modern era is the capacity that larger drug store chains have for buying pharmaceutical products in bulk, thereby getting larger supplies at reduced costs. Those difficulties have been exacerbated as the pharmacy benefit managers (PBMs) designed to process claims for pharmacies have turned to working for Medicare, Medicaid and commercial health plans – their aim now to manage pharmaceutical benefits and keep insurers’ costs low (http://ibn.fm/CniN7).

A news media series of reports on ‘pharmacy deserts’ cropping up across Ohio and elsewhere in the United States (http://ibn.fm/11Fpk) as independent businesses close their doors expresses particular concern about the strain created by low reimbursement rates for state Medicaid patient coverage. Even many physicians are turning away potential patients over the state insurers’ record of poor reimbursement and complicated procedures for obtaining reimbursement (http://ibn.fm/sw932).

When the independent, locally owned businesses suffer, patients suffer as well. After the CVS network bought and closed the Lonsinger Pharmacy in Danville, Ohio, two years ago, the town’s librarian told The Columbis Dispatch (http://ibn.fm/Ysr0Q) that one elderly resident “broke down crying… He said, ‘I can’t walk to Mount Vernon’ (the nearest town where a pharmacy could now be found), but he could walk to Lonsinger’s.” When a Manchester, Connecticut, pharmacy sold its accounts to the national chain this month, one employee reminisced (http://ibn.fm/QvIiO) about how the local employees had “really gone the extra mile, gone to people’s homes, fixed (medicine) boxes, or helped with dosages. On our way home from closing our store at night we made deliveries.”

“That’s what’s good about independent pharmacies. The people that work here, we’re a family,” a former employee at a now-closed independent pharmacy in a Maryland town noted in an article published by The Baltimore Sun (http://ibn.fm/j3IwK).

Trxade Group is working to empower independently owned pharmacies and help them manage their operations through data analysis resources that note where a demand for their products is likely to occur and predictively pairs that information with data on product availability and costs.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• Neutra Corp. is working to establish its position within the rapidly growing hemp-based product and CBD markets
• The company’s recent acquisition of J3 Holdings will give Neutra Corp. access to J3 Holdings’ land, warehouse and hemp cultivation license, allowing it to ensure the quality of ingredients used in product development
• Neutra Corp. also announced the acquisition of Vivis, an emerging retail brand of hemp-based health and nutritional products that are third-party certified

Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, recently announced a couple of important moves in line with its corporate expansion and vertical integration CBD market strategy.

On July 24, 2019, Neutra Corp. announced its entry into a letter of intent for the acquisition of J3 Holdings (http://ibn.fm/QIaX1), which currently owns land and a warehouse, as well as a license for hemp cultivation and refining into usable forms. Through the move, Neutra will become capable of cultivating, manufacturing and distributing hemp-based CBD products.

For some time, Neutra had been concentrating its efforts on the development of hemp-based CBD products. With the latest acquisition, it aims to become capable of growing its own hemp supply to ensure the quality of ingredients.

On July 26, Neutra Corp. announced another very important acquisition to strengthen its CBD market position even further (http://ibn.fm/kq4VM). The company signed a letter of intent for the acquisition of Vivis, an emerging retail brand of hemp-based health and nutritional products.

Vivis CBD products are third-party certified as containment-free and of consistent quality and potency, Neutra Corp. President Sydney Jim said in a news release. Consumers are becoming more interested in products that have such certification, which could increase the demand for Neutra products upon completion of the Vivis acquisition, he concluded.

Neutra is working to establish its position in the particularly lucrative CBD market. According to industry forecasts, hemp-based product sales could reach $22 billion by 2022. Several factors contribute to the growth, including rapid legalization, higher levels of consumer awareness and significantly more research being conducted into the health benefits of CBD.

The range of CBD products is constantly growing. Currently, it includes oils, creams, supplements, analgesics, beverages, edibles and various others. CBD can also be inhaled to deliver anti-depression benefits, anti-inflammatory effects, pain relief and relief from the symptoms of neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Unlike other compounds, CBD does not cause addiction. It also avoids the typical high that stems from THC use.

According to Sydney Jim, the CBD market offers tremendous opportunities. This is the main reason why Neutra Corp. will continue targeting the sector moving forward, he concluded.

To cement its market position, Neutra Corp. has been actively looking for partners and acquisitions in the hemp-derived product niche for over eight months.

For more information, visit the company’s website at www.NutraInc.com

• Plans are already in place to expand Grapefruit’s state-of-the-art extraction facility
• The company is dedicated to distributing its own products and providing high-quality cannabis commodities to customers
• Grapefruit’s newest product demonstrates the company’s capabilities and serves as a flagship of its edibles line

Grapefruit Boulevard Investments Inc. (OTCQB: IGNG), a fully licensed cannabis manufacturer and distributor in California, is fast becoming recognized in the industry for its quality product lines. Those products – including Rainbow Dreams, Grapefruit’s most recent offering – adhere strictly to the company’s motto and commitment to offer “a high you can trust.”

That commitment starts at the heart of the company’s operations – its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. Widely recognized as a hub for quality cannabis activity, the Coachillin’ location is the perfect backdrop for Grapefruit’s manufacturing and distribution operations.

Grapefruit began extraction in May and already has expansion plans in place that will allow the growing company to increase efficiencies and output. The company plans to build a state-of-the-art, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy and large extraction lab; a manufacturing space to produce its vape lines and CBD products; an FDA-certified kitchen for the production of Grapefruit edibles; and a distribution facility for selling all products throughout the entire cannabis marketplace. The new structure is expected to be built adjacent to the company’s current operations in the Coachillin’ park.

Grapefruit’s dedication to quality and service means that, in addition to being able to offer a large and diverse inventory of superior cannabis products that can be delivered within 24 hours of order, the company’s wholesale distribution arm will also offer high-quality, competitively priced raw materials to other manufacturers and distributors. Grapefruit’s extraction lab produces high-quality distillate or ‘honey oil’, a universal product used in everything from infused edibles and tinctures/creams to the ‘fuel’ used in vapes and e-cigarettes. Honey oil is a highly sought out item on the cannabis market, and Grapefruit’s commitment to premium quality ingredients will enable the company to demand top dollar for its cannabis products. Utilizing biomass cultivated in its own indoor grow canopy operation, Grapefruit aims to position itself for high revenue potential.

In addition to expanding its extraction lab, Grapefruit recently strengthened its position as a growing presence in the cannabis space with the launch of its newest brand, Rainbow Dreams, a unique line of newly formulated and flavored CBD- and THC-infused cannabis oil vaporization cartridges. Rainbow Dreams is made from the most trusted oils and highest-quality, authentic CCELL ceramic vaporizer cartridges, ensuring the most consistent and smooth product delivery available in the industry today. The four new Rainbow Dream vape cartridges each offer a unique flavor profile, including mango passion, citrus bliss, berry delight and strawberry ice.

“Moving the Rainbow Dreams project forward demonstrates our team’s ability to bring a high-quality product to market at a competitive price,” Grapefruit CEO Bradley J. Yourist stated in a news release (http://ibn.fm/gLj02). “Flavored and full-spectrum cannabis oils… are growing in popularity in California and elsewhere because customers in the recreational market want a no burn-flavored oil without any offending cannabis smell. Our Rainbow Dreams products deliver on this… It is our experience that some customers like a more CBD- and CBN-heavy formulated oil for help with pain and sleep.”

Yourist indicated that Rainbow Dreams will be the flagship for Grapefruit’s new cartridges, which are planned for release within the next 45 days.

“By implementing our own high-end, custom-formulated vaporization cartridge line, Grapefruit believes it will capture significant revenue opportunities as we move inexorably toward our goal of becoming a leading, fully integrated, licensed and compliant cannabis-product manufacturing and distribution company,” Yourist added.

Grapefruit holds California licenses to both manufacture and distribute cannabis products. The company’s vision is to become a seed-to-sale, fully vertically integrated, ethical and compliant cannabis and CBD product company. The company works to manufacture, procure and distribute only the highest-quality, all-natural cannabis honey oil, edibles, flowers, concentrates and related products that are free from pesticides, heavy metals and bacteria.

For more information, visit the company’s website at www.GrapefruitBlvd.com

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://ibn.fm/IGNG

• Health Canada is enforcing mandatory cannabis testing for the presence of pesticide active ingredients; unauthorized pesticide use can result in seizure or recall of product, suspension/revocation of licenses and penalties of up to $1 million
• MustGrow is seeking Health Canada approval for its patented biopesticide as a natural, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production
• A joint research and development program with the National Research Council Canada is underway, with a focus on the efficacy of MustGrow’s biopesticides for use in cannabis production
• MustGrow’s safe and effective natural products are EPA- and PRMA-approved and registered for use on fruits, vegetables, turf and ornamental crops

MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizer products for the cannabis industry, is continuing its joint research and development program with the National Research Council Canada (NRC). The NRC is an agency of the government of Canada whose research and development divisions are focused on supporting innovation efforts in key industry sectors, including the rapidly expanding cannabis marketplace (http://ibn.fm/gCar2).

MustGrow’s biopesticide R&D program with the NRC targets an issue plaguing licensed cannabis producers who must follow regulatory guidelines when it comes to using pesticides or pest control products (“PCP”) in growing and manufacturing cannabis products. Under the Cannabis Act, license holders may only use certain PCPs that have been approved for use on cannabis by the Pest Management and Regulatory Agency (http://ibn.fm/liqhz).

MustGrow and the NRC are conducting a series of efficacy assessments of MustGrow’s patented natural biopesticide as a natural pre-plant, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production (http://ibn.fm/T5jTD). MustGrow’s products are refined from compounds of the mustard plant, utilizing the plant’s natural defense mechanism as a pre-plant soil biopesticide treatment (http://ibn.fm/UAulS) and are shown to deliver effective pathogen and pest control to ensure plant growth and high yields in a variety of agricultural settings (http://ibn.fm/zsuSl).

Canada’s licensed producers (LPs) are required by law to demonstrate that no unauthorized pesticides were used on their products or contaminated them (http://ibn.fm/oo6wQ), and mandatory testing is underway to ensure that LPs comply. Failure of Health Canada’s sampling and testing program for unauthorized pest control products could result in product seizure or destruction, recall of products sold, suspension or revocation of the firm’s license, or a monetary penalty of up to C$1 million, according to Health Canada.

Through MustGrow’s eventual suite of biostimulant/biofertilizer offerings, Canadian cannabis license holders may have access to products that aid in the production of compliant, pest-free cannabis. MustGrow’s science-based suite of signature products have already demonstrated control of many soil-borne diseases and pests that affect cannabis production, including Botrytis (grey mold), Pythium root rot, Rhizoctonia fungus, Fusarium, nematodes, Verticillium wilt, Phytophthora root rot and Sclerotinia. MustGrow’s products are recognized as safe and are EPA- and PRMA-approved for use on fruits and vegetables.

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• SinglePoint is building an extensive portfolio of undervalued subsidiaries
• The company recently gave a shareholder overview detailing its new initiatives
• SinglePoint’s merchant services portfolio continues to grow

SinglePoint Inc. (OTCQB: SING) specializes in acquisitions of small to mid-sized firms and is focused on diversification into horizontal markets. The company’s emphasis is on new technologies, and its varied assets include payment processing, cannabis and more. Headquartered in Phoenix, Arizona, SinglePoint provides investors with an opportunity to gain exposure to a broad array of assets.

SinglePoint is building an impressive portfolio of undervalued subsidiaries that offer a varied holding base with multiple streams of revenue (http://ibn.fm/2Kov4). The company is taking advantage of its technological expertise to develop opportunities in the cannabis market, and, since 2014, SinglePoint has been providing ancillary solutions and investing in or acquiring businesses that provide services or offerings to the hemp and cannabis industries.

SinglePoint is eyeing opportunities to implement its payments expertise into accounts including CBD and cannabis clients. The company can support online and instore payments for business of all kinds and plans to continue alternative payments rollouts through the use of blockchain-based solutions.

Recently, SinglePoint provided a shareholder update overviewing its important growth initiatives. These initiatives involve solar, hemp and merchant services. The company’s most recent acquisition was that of Direct Solar, whose offerings span both commercial solar applications and renewable-energy financing options. Direct Solar enables residential solar customers to shop their options so that they can find the best offerings for their homes (http://ibn.fm/vw8gU).

Fundamentally, Direct Solar offers an innovative solution for lenders, building owners and management teams. For lenders, the firm provides verified projects with vetted services providers. Lenders offer Direct Solar their lists of requirements in order to fund a project. Subsequently, lenders receive only projects that fit within those parameters. For commercial customers, Direct Solar provides a one-stop shop where they can apply for and receive financing for their projects upon approval. In its first 60 days, Direct Solar contracted more than $3 million in residential solar contracts.

Furthermore, SinglePoint has its hemp-derived CBD (cannabidiol) offerings. SingleSeed is the company’s consumer-facing CBD brand, and it has been progressively building sales via its ecommerce site, SingleSeed.com. SingleSeed is now working on distribution agreements to bring hemp-derived CBD products to retail stores.

Moreover, SingleSeed is leveraging opportunities to manufacture products for consumers. Through its DIGS subsidiary, SingleSeed has leased a property in Carlsbad, California, to manufacture and distribute products ranging from hemp topicals to tinctures and capsules.

SinglePoint is also concentrating once again on payments and merchant services. The company is working to take on all kinds of businesses, including high-risk ventures such as cannabis and hemp, auto mechanic shops and restaurants. SinglePoint has acquired many new merchants recently and is currently building its strategy around bringing in more contractors to quickly scale its merchant services team.

SinglePoint continues to focus on its strategy to drive revenue growth through partnerships, equity-financed acquisitions and internal product development. The company offers investors a door to emerging technologies that have the potential for significant ROI, putting SinglePoint at the vanguard of innovation in new verticals.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING